the Dorgan-Snowe bill, pending before the Senate as an amendment, eliminates language from the Food, Drug, and Cosmetic Act that allows importation to take effect only if the Secretary of Health and Human Services can demonstrate to Congress that it will pose no additional risk to the public health and result in a significant reduction in the cost of covered products to the American consumer. The amendment I have offered to the Dorgan-Snowe bill would restore this language. The Senate has overwhelmingly voted on three occasions to include a safety and savings certification provision in prescription drug importation legislation for the purpose of protecting the public health. Following passage of the safety and savings certification requirement, no Secretary of HHS, Democrat or Republican, has been able to demonstrate that importation is safe or will lead to cost savings. Both Secretary Shalala in the Clinton administration and Secretary Thompson in the Bush administration could not demonstrate that importation poses no additional risk to public health or would lead to significant cost savings.
Thad Cochran: “the Dorgan-Snowe bill, pending before the Senate as an amendment, eliminates language from the Food, Drug, and Cosmetic…”
Editor's note · Context
Discussing the Dorgan-Snowe bill and its implications for drug importation safety and cost.
Share
More from Thad Cochran
I am concerned that the 22 percent funding cut proposed for NIH could negatively affect longstanding research endeavors.
I would like to bring attention to an important anniversary in the history of the U.S. Senate. Today marks the 150th anniversary of the creation of the Senate Committee on Appropriations. In 1867, the Senate passed a resolution creating a…
I think the complementary and coordination of biomedical research with the Department of Defense, the VA, and NIH is very important.
And I plan to use my best efforts to identify the areas that we can make improvements in, and take a hard look, but at the same time realize we need to get a bill.





